Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Brain Neoplasms × Saline Solution × Clear all

Phase

Phase 4 4 Phase NA 3 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urologic Neoplasms 1 Lipoma 1 Leiomyoma 1 Hemorrhage 1 Hearing Loss 1 Ear Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Temozolomide 34 Radiosurgery 20 Radiotherapy 19 Cyclophosphamide 11 Radiation 10 Etoposide 10 Magnetic Resonance Spectroscopy 9 Irinotecan 9 Filgrastim 8 Carboplatin 8 pembrolizumab 7 Surgical Procedures, Operative 7 Erlotinib Hydrochloride 7 Carmustine 7 Bevacizumab 7 Vincristine 6 Sorafenib 6 Flucytosine 6 temsirolimus 5 O(6)-benzylguanine 5 Nivolumab 5 Imatinib Mesylate 5 Granulocyte Colony-Stimulating Factor 5 Everolimus 5 Aminolevulinic Acid 5 sargramostim 4 cediranib 4 Vorinostat 4 Valproic Acid 4 Trastuzumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03177252 2020-10-22

Scalp block

Washington University School of Medicine

Phase 1 Withdrawn

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡